From the results of our cohort study, we believe that the plasma testosterone level, or SHBG level may not affect the development of prostatic hyperplasia because plasma levels of androgens may not accurately reflect their concentrations within the prostate gland. This evidence concerns the gene SHBG and prostate disorder.